Vitenskapelig artikkel

• Lama AlAbdi; Abdullah Sezer; Fatema Alzahrani et al. (2026). Bi-allelic variants in OLA1 cause a neurodevelopmental disorder with joint hypermobility. (ekstern lenke)
• Isil Kucuka; Anette Susanne Bøe Wolff; Lars Breivik et al. (2026). Long-term follow-up of autoimmune polyendocrine syndrome type-1 in Norway. (ekstern lenke)
• Torunn Hjøllo; Eirik Bratland; Hans Steinsland et al. (2018). Longitudinal cohort study of serum antibody responses towards Giardia lamblia variant-specific surface proteins in a non-endemic area. (ekstern lenke)
• Kine Susann Waade Edvardsen; Alexander Hellesen; Eystein Sverre Husebye et al. (2016). Analysis of cellular and humoral immune responses against cytomegalovirus in patients with autoimmune Addison's disease. (ekstern lenke)
• Thea Sjøgren; Eirik Bratland; Ellen Christine Røyrvik et al. (2022). Screening patients with autoimmune endocrine disorders for cytokine autoantibodies reveals monogenic immune deficiencies. (ekstern lenke)
• Iivo Hetemäki; Hanna Jarva; Nicolas Kluger et al. (2016). Anticommensal responses are associated with regulatory T cell defect in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy patients. (ekstern lenke)
• Eystein S.Junior Husebye; Eirik Bratland; Geir Bredholt et al. (2006). The substrate-binding domain of 21-hydroxylase, the main autoantigen in autoimmune Addison's disease, is an immunodominant T cell epitope. (ekstern lenke)
• Ingeborg Brønstad; Lars Ertesvåg Breivik; Paal Methlie et al. (2014). Functional studies of novel CYP21A2 mutations detected in Norwegian patients with congenital adrenal hyperplasia. (ekstern lenke)
• Marianne Astor; Kristian Løvås; Anette Susanne Bøe Wolff et al. (2015). Hypomagnesemia and functional hypoparathyroidism due to novel mutations in the Mg-channel TRPM6. (ekstern lenke)
• Gerarda Cappuccio; Camilla Ceccatelli Berti; Enrico Baruffini et al. (2021). Bi-allelic KARS1 pathogenic variants affecting functions of cytosolic and mitochondrial isoforms are associated with a progressive and multisystem disease. (ekstern lenke)
• Eirik Bratland; B Skinningsrud; Dag Erik Undlien et al. (2009). T Cell Responses to Steroid Cytochrome P450 21-Hydroxylase in Patients with Autoimmune Primary Adrenal Insufficiency. (ekstern lenke)
• Tinatin Tkemaladze; Eirik Bratland; Kakha Bregvadze et al. (2023). MSMO1 deficiency: a potentially partially treatable, ultrarare neurodevelopmental disorder with psoriasiform dermatitis, alopecia and polydactyly. (ekstern lenke)
• Mohummad Aminur Rahman; Jorunn Brekke; Victoria Smith Arnesen et al. (2020). Sequential bortezomib and temozolomide treatment promotes immunological responses in glioblastoma patients with positive clinical outcomes: A phase 1B study. (ekstern lenke)
• Eirik Bratland; Geir Bredholt; Gunnar Mellgren et al. (2009). The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: The major autoantigen in autoimmune Addison's disease. (ekstern lenke)
• Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff; Eirik Bratland et al. (2008). Radioimmunoassay for autoantibodies against interferon omega; its use in the diagnosis of autoimmune polyendocrine syndrome type I. (ekstern lenke)
• Sigrid Aslaksen; Anette Susanne Bøe Wolff; Magnus Dehli Vigeland et al. (2019). Identification and characterization of rare Toll-like receptor 3 variants in patients with autoimmune Addison’s disease. (ekstern lenke)
• Bergithe Eikeland Oftedal; Amund Holte Berger; Øyvind Bruserud et al. (2023). A partial form of AIRE deficiency underlies a mild form of autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Eirik Bratland; Eystein Sverre Husebye (2011). Cellular immunity and immunopathology in autoimmune Addison’s disease. (ekstern lenke)
• Ingeborg Brønstad; Beate Skinningsrud; Eirik Bratland et al. (2014). CYP21A2 polymorphisms in patients with autoimmune Addison's disease, and linkage disequilibrium to HLA risk alleles. (ekstern lenke)
• Bergithe Eikeland Oftedal; Alexander Hellesen; Martina Moter Erichsen et al. (2015). Dominant mutations in the autoimmune regulator AIRE are associated with common organ-specific autoimmune diseases. (ekstern lenke)
• Sigrid Aslaksen; Paal Methlie; Magnus Dehli Vigeland et al. (2019). Coexistence of congenital adrenal hyperplasia and autoimmune Addison's disease. (ekstern lenke)
• Kine Susann Waade Edvardsen; Trine Elholm Bjånesøy; Alexander Hellesen et al. (2015). Peripheral blood cells from patients with autoimmune Addison's disease poorly respond to interferons in vitro, despite elevated serum levels of interferon-inducible chemokines. (ekstern lenke)
• Gunnar Douzgos Houge; Eirik Bratland; Ingvild Aukrust et al. (2024). Comparison of the ABC and ACMG systems for variant classification. (ekstern lenke)
• Øyvind Bruserud; Eirik Bratland; Alexander Hellesen et al. (2017). Altered immune activation and IL-23 signaling in response to Candida albicans in autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Anette Susanne Bøe Wolff; Lars Ertesvåg Breivik; Karl Ove Hufthammer et al. (2021). The natural history of 21-hydroxylase autoantibodies in autoimmune Addison’s disease. (ekstern lenke)
• Marzieh Bahador; Andrea Gras Navarro; Mohummad Aminur Rahman et al. (2017). Increased infiltration and tolerised antigen-specific CD8+ TEM cells in tumor but not peripheral blood have no impact on survival of HCMV+ glioblastoma patients. (ekstern lenke)
• Lars Ertesvåg Breivik; Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff et al. (2014). A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Elinor Margrethe Vogt; Eirik Bratland; Siren Berland et al. (2024). Improving diagnostic precision in primary ovarian insufficiency using comprehensive genetic and autoantibody testing. (ekstern lenke)
• Haydee Artaza; Daniel Eriksson; Ksenia Lavrichenko et al. (2024). Rare copy number variation in autoimmune Addison’s disease. (ekstern lenke)
• Eirik Bratland; Anette Susanne Bøe Wolff; Jan Haavik et al. (2007). Epitope mapping of human aromatic L-amino acid decarboxylase. (ekstern lenke)
• Åse Bjorvatn Sævik; Anette Susanne Bøe Wolff; Sigridur Björnsdottir et al. (2021). Potential Transcriptional Biomarkers to Guide Glucocorticoid Replacement in Autoimmune Addison's Disease. (ekstern lenke)
• Eirik Bratland; Alexander Hellesen; Eystein Sverre Husebye (2013). Induction of CXCL10 chemokine in adrenocortical cells by stimulation through toll-like receptor 3. (ekstern lenke)
• Trine Elholm Bjånesøy; Bettina Kulle; Eirik Bratland et al. (2014). Altered DNA methylation profile in Norwegian patients with Autoimmune Addison's Disease. (ekstern lenke)
• Sigrid Aslaksen; Ingvild Aukrust; Laurie Molday et al. (2024). Functional Characterization of ABCA4 Missense Variants Aids Variant Interpretation and Phenotype Prediction in Patients With ABCA4-Retinal Dystrophies. (ekstern lenke)
• Daniel Eriksson; Ellen Christine Røyrvik; Maribel Aranda-Guillen et al. (2021). GWAS for autoimmune Addison's disease identifies multiple risk loci and highlights AIRE in disease susceptibility. (ekstern lenke)
• Amina Dawoodji; Ji-Li Chen; Dawn Shepherd et al. (2014). High frequency of cytolytic 21-hydroxylase-specific CD8+ T cells in autoimmune Addison's disease patients. (ekstern lenke)
• Megan L. Corder; Siren Berland; Jostein Andersen Førsvoll et al. (2021). Truncating and zinc-finger variants in GLI2 are associated with hypopituitarism. (ekstern lenke)
• Gry Hoem; Arianna Pastore; Eirik Bratland et al. (2024). Severe isolated exudative vitreoretinopathy caused by biallelic FZD4 variants. (ekstern lenke)
• Alexander Hellesen; Eirik Bratland; Eystein Sverre Husebye (2018). Autoimmune Addison's disease – An update on pathogenesis. (ekstern lenke)
• Katherine A. Kentistou; Lena R. Kaisinger; Stasa Stankovic et al. (2024). Understanding the genetic complexity of puberty timing across the allele frequency spectrum. (ekstern lenke)
• Alexander Hellesen; Eirik Bratland (2018). The potential role for infections in the pathogenesis of autoimmune Addison?s disease. (ekstern lenke)
• Alexander Hellesen; Sigrid Aslaksen; Lars Ertesvåg Breivik et al. (2021). 21-Hydroxylase-Specific CD8+ T Cells in Autoimmune Addison’s Disease Are Restricted by HLA-A2 and HLA-C7 Molecules. (ekstern lenke)
• Marta Fichna; Magdalena Zurawek; Eirik Bratland et al. (2015). Interleukin-2 and subunit alpha of its soluble receptor in autoimmune Addison's disease - An association study and expression analysis. (ekstern lenke)
• Richard Alexander Hellesen; Kine Susann Waade Edvardsen; Lars Ertesvåg Breivik et al. (2014). The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease. (ekstern lenke)
• Peter Taule-Sivertsen; Ove Bruland; Aril Løge Håvik et al. (2021). The SH3PXD2A-HTRA1 fusion transcript is extremely rare in Norwegian sporadic vestibular schwannoma patients. (ekstern lenke)
• Amund Holte Berger; Bergithe Eikeland Oftedal; Anette Susanne Bøe Wolff et al. (2025). High-resolution transcriptional impact of AIRE: effects of pathogenic variants p.Arg257Ter, p.Cys311Tyr, and polygenic risk variant p.Arg471Cys. (ekstern lenke)
• Amund Holte Berger; Eirik Bratland; Thea Sjøgren et al. (2021). Transcriptional changes in regulatory T cells from patients with autoimmune polyendocrine syndrome type 1 suggest functional impairment of lipid metabolism and gut homing. (ekstern lenke)
• Øyvind Bruserud; Bergithe Eikeland Oftedal; Nils Landegren et al. (2016). A longitudinal follow-up of autoimmune polyendocrine syndrome type 1. (ekstern lenke)
• Yael Goldfarb; Tal Givony; Noam Kadouri et al. (2021). Mechanistic dissection of dominant AIRE mutations in mouse models reveals AIRE autoregulation. (ekstern lenke)
• Eirik Bratland; Ng'weina Francis Magitta; Anette Susanne Bøe Wolff et al. (2013). Autoantibodies against aromatic amino acid hydroxylases in patients with autoimmune polyendocrine syndrome type 1 target multiple antigenic determinants and reveal regulatory regions crucial for enzymatic activity. (ekstern lenke)

Leserbrev

• Daniëla Maria Hinke; Sofie R. Dorset; Eirik Bratland et al. (2025). CXCR2 deficiency with myelokathexis caused by a novel variant: Correction via CRISPR/Cas. (ekstern lenke)

Doktorgradsavhandling

• Eirik Bratland (2009). Cellular immunity in autoimmune Addison's disease : T cell responses to steroid cytochrome P450 21-hydroxylase. (ekstern lenke)
• Kine Susann Waade Edvardsen; Eirik Bratland (2015). Autoimmunity and viral immunity in Addison’s disease. (ekstern lenke)
• Alexander Hellesen; Eirik Bratland (2016). Immuno-endocrine interactions in autoimmune Addison's disease. (ekstern lenke)

Konferanseabstrakt

• I Hetemaki; H Jarva; H. Tervo et al. (2012). Increased antibody levels against gut commensals are associated with regulatory T cell defect in patients with APECED. (ekstern lenke)
• Ingeborg Brønstad; Beate Skinningsrud; Anette Susanne Bøe Wolff et al. (2013). Characterisation of the CYP21A2 Gene in Patients with Autoimmune Addison's Disease. (ekstern lenke)
• Eirik Bratland; Richard Alexander Hellesen; Eystein Sverre Husebye (2012). Mice deficient for the autoimmune regulator, Aire, display altered T cell responses against 21-hydroxylase, the major autoantigen in autoimmune Addison's disease. (ekstern lenke)
• Eirik Bratland; Eystein Sverre Husebye (2008). 21-hydroxylase as a T cell autoantigen in autoimmune Addison's disease. (ekstern lenke)
• Eirik Bratland; Anette Susanne Bøe Wolff; Jan Haavik et al. (2007). Epitope mapping of human aromatic L-amino acid decarboxylase. (ekstern lenke)
• Eirik Bratland; Eystein Sverre Husebye (2010). The Possible Roles of Interferon-Gamma, CXC Chemokine Ligand 10 (CXCL10) and the CXCR3 Circuit in the Pathogenesis of Autoimmune Addison's Disease. (ekstern lenke)
• A Hellesen; Eirik Bratland; Eystein Sverre Husebye (2012). Poly (I:C)-induced CXCL10 production in adrenocortical cells - implications for autoimmune Addison's disease?. (ekstern lenke)
• Richard Alexander Hellesen; Eirik Bratland; Eystein Sverre Husebye (2011). Endogenous Production of CXC Chemokine Ligand 10 (CXCL10) by Adrenocortical Cells and its Implications for Autoimmune Addison's Disease. (ekstern lenke)

Rettelse i tidsskrift

• Katherine A. Kentistou; Lena R. Kaisinger; Stasa Stankovic et al. (2024). Correction to: Understanding the genetic complexity of puberty timing across the allele frequency spectrum (Nature Genetics, (2024), 56, 7, (1397-1411), 10.1038/s41588-024-01798-4). (ekstern lenke)

Konferanseposter

• Lars Ertesvåg Breivik; Bergithe Eikeland Oftedal; Eirik Bratland et al. (2013). A novel cell-based assay for measuring neutralizing autoantibodies against type I interferons in patients with APS-1. (ekstern lenke)

Se en fullstendig oversikt over publikasjoner i NVA.